vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and InvenTrust Properties Corp. (IVT). Click either name above to swap in a different company.
InvenTrust Properties Corp. is the larger business by last-quarter revenue ($77.4M vs $62.1M, roughly 1.2× Cytek Biosciences, Inc.). InvenTrust Properties Corp. runs the higher net margin — 3.4% vs -70.9%, a 74.4% gap on every dollar of revenue. On growth, InvenTrust Properties Corp. posted the faster year-over-year revenue change (8.6% vs 8.1%). InvenTrust Properties Corp. produced more free cash flow last quarter ($110.9M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 7.6%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
InvenTrust Properties Corp. is a real estate investment trust that invests in shopping malls. As of December 31, 2024, the company owned interests in 68 properties comprising 11.0 million square feet.
CTKB vs IVT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $77.4M |
| Net Profit | $-44.1M | $2.7M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | -11.0% |
| Net Margin | -70.9% | 3.4% |
| Revenue YoY | 8.1% | 8.6% |
| Net Profit YoY | -557.1% | -72.8% |
| EPS (diluted) | — | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $77.4M | ||
| Q3 25 | $52.3M | $74.5M | ||
| Q2 25 | $45.6M | $73.6M | ||
| Q1 25 | $41.5M | $73.8M | ||
| Q4 24 | $57.5M | $71.2M | ||
| Q3 24 | $51.5M | $68.5M | ||
| Q2 24 | $46.6M | $67.4M | ||
| Q1 24 | $44.9M | $66.8M |
| Q4 25 | $-44.1M | $2.7M | ||
| Q3 25 | $-5.5M | $6.0M | ||
| Q2 25 | $-5.6M | $95.9M | ||
| Q1 25 | $-11.4M | $6.8M | ||
| Q4 24 | $9.6M | $9.8M | ||
| Q3 24 | $941.0K | $-539.0K | ||
| Q2 24 | $-10.4M | $1.5M | ||
| Q1 24 | $-6.2M | $2.9M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | -11.0% | ||
| Q3 25 | -17.6% | -9.8% | ||
| Q2 25 | -23.3% | — | ||
| Q1 25 | -36.1% | -10.5% | ||
| Q4 24 | 5.2% | -3.6% | ||
| Q3 24 | -8.2% | -18.7% | ||
| Q2 24 | -18.3% | -13.6% | ||
| Q1 24 | -23.9% | -13.1% |
| Q4 25 | -70.9% | 3.4% | ||
| Q3 25 | -10.5% | 8.1% | ||
| Q2 25 | -12.2% | 130.4% | ||
| Q1 25 | -27.5% | 9.2% | ||
| Q4 24 | 16.8% | 13.8% | ||
| Q3 24 | 1.8% | -0.8% | ||
| Q2 24 | -22.4% | 2.2% | ||
| Q1 24 | -13.8% | 4.3% |
| Q4 25 | — | $0.02 | ||
| Q3 25 | — | $0.08 | ||
| Q2 25 | — | $1.23 | ||
| Q1 25 | — | $0.09 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $0.02 | ||
| Q1 24 | — | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | $825.9M |
| Stockholders' EquityBook value | $341.7M | $1.8B |
| Total Assets | $461.5M | $2.8B |
| Debt / EquityLower = less leverage | — | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
| Q4 25 | — | $825.9M | ||
| Q3 25 | — | $764.6M | ||
| Q2 25 | — | $746.3M | ||
| Q1 25 | — | $740.7M | ||
| Q4 24 | — | $740.4M | ||
| Q3 24 | — | $740.1M | ||
| Q2 24 | — | $812.2M | ||
| Q1 24 | — | $827.5M |
| Q4 25 | $341.7M | $1.8B | ||
| Q3 25 | $378.6M | $1.8B | ||
| Q2 25 | $377.6M | $1.8B | ||
| Q1 25 | $379.6M | $1.7B | ||
| Q4 24 | $395.7M | $1.8B | ||
| Q3 24 | $385.5M | $1.8B | ||
| Q2 24 | $389.1M | $1.5B | ||
| Q1 24 | $392.6M | $1.5B |
| Q4 25 | $461.5M | $2.8B | ||
| Q3 25 | $494.9M | $2.7B | ||
| Q2 25 | $493.3M | $2.7B | ||
| Q1 25 | $482.6M | $2.6B | ||
| Q4 24 | $499.5M | $2.6B | ||
| Q3 24 | $491.2M | $2.6B | ||
| Q2 24 | $483.7M | $2.5B | ||
| Q1 24 | $492.1M | $2.5B |
| Q4 25 | — | 0.46× | ||
| Q3 25 | — | 0.42× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 0.42× | ||
| Q4 24 | — | 0.42× | ||
| Q3 24 | — | 0.42× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $155.4M |
| Free Cash FlowOCF − Capex | $-1.8M | $110.9M |
| FCF MarginFCF / Revenue | -2.9% | 143.3% |
| Capex IntensityCapex / Revenue | 1.6% | 57.5% |
| Cash ConversionOCF / Net Profit | — | 58.41× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $193.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $155.4M | ||
| Q3 25 | $-3.9M | $43.8M | ||
| Q2 25 | $108.0K | $48.7M | ||
| Q1 25 | $-125.0K | $20.2M | ||
| Q4 24 | $2.0M | $136.9M | ||
| Q3 24 | $13.2M | $38.4M | ||
| Q2 24 | $6.2M | $46.7M | ||
| Q1 24 | $4.0M | $14.8M |
| Q4 25 | $-1.8M | $110.9M | ||
| Q3 25 | $-4.6M | $31.4M | ||
| Q2 25 | $-1.5M | $38.0M | ||
| Q1 25 | $-974.0K | $12.8M | ||
| Q4 24 | $1.1M | $100.8M | ||
| Q3 24 | $12.2M | $29.3M | ||
| Q2 24 | $5.2M | $37.2M | ||
| Q1 24 | $3.4M | $7.7M |
| Q4 25 | -2.9% | 143.3% | ||
| Q3 25 | -8.7% | 42.2% | ||
| Q2 25 | -3.2% | 51.6% | ||
| Q1 25 | -2.3% | 17.4% | ||
| Q4 24 | 1.9% | 141.5% | ||
| Q3 24 | 23.7% | 42.8% | ||
| Q2 24 | 11.0% | 55.2% | ||
| Q1 24 | 7.6% | 11.5% |
| Q4 25 | 1.6% | 57.5% | ||
| Q3 25 | 1.3% | 16.7% | ||
| Q2 25 | 3.5% | 14.6% | ||
| Q1 25 | 2.0% | 10.0% | ||
| Q4 24 | 1.6% | 50.7% | ||
| Q3 24 | 2.0% | 13.3% | ||
| Q2 24 | 2.3% | 14.0% | ||
| Q1 24 | 1.3% | 10.6% |
| Q4 25 | — | 58.41× | ||
| Q3 25 | — | 7.27× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 2.97× | ||
| Q4 24 | 0.21× | 13.97× | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | 31.15× | ||
| Q1 24 | — | 5.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
IVT
Segment breakdown not available.
